HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Can Avon CEO McCoy Rise To “Superhuman” Task?

This article was originally published in The Rose Sheet

Executive Summary

New CEO Sheri McCoy comes to Avon from Johnson & Johnson with a strong background in consumer products and a “significant turn-around track record,” according to Avon. However, “there is no cape flowing behind her,” notes Morningstar analyst Lauren DeSanto, speculating that Avon’s problems may require superhuman powers.

You may also be interested in...



J&J Picks Outsider With Broad Experience To Lead Consumer Group

Bayer CropScience CEO Sandra Peterson will join Johnson & Johnson Dec. 1 as group worldwide chairman with oversight of consumer companies, IT and global supply chain. Worldwide Consumer Group Chairman Jesse Wu will report to Peterson, who also takes a seat on J&J’s executive committee.

Avon’s Dismal Q1 Makes Coty Bid More Appealing – Analysts

The first fiscal quarter of 2012 was “unexpectedly weak” for Avon Products, with sales down 2% to $2.6 billion and net income plummeting 82% to $26.5 million, making clear the challenges ahead for the firm and its new CEO. Analysts believe Coty may have a better chance of acquiring the New York-based direct seller in light of the Q1 results.

Coty Makes Offer For Avon, Smelling “Blood in the Water” – Analyst

Coty envisions “an iconic beauty company” to emerge from its proposed acquisition of Avon; however, the direct seller’s management has dismissed the offer as “opportunistic” and not in shareholders’ best interest. Coty is now appealing directly to shareholders, highlighting the firms’ complementary product portfolios and geographical strengths. Meanwhile, Avon seems intent on finding growth and profitability on its own.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel